Paper12370120
Development of cDNA microarray for expression profiling of estrogen-responsive genes.
Inoue A and 6 others. J Mol Endocrinol, 2002. Cited by 183 papers, by iCite.
Cite this record
ConductScience Library. Development of cDNA microarray for expression profiling of estrogen-responsive genes. Papers, record 12370120. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12370120
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Estrogens | Major topic |
| Gene Expression Profiling | Major topic |
| Oligonucleotide Array Sequence Analysis | Major topic |
| Blotting, Northern | |
| Breast Neoplasms | |
| Estradiol | |
| Estrogen Antagonists | |
| Estrogen Receptor alpha | |
| Female | |
| Humans | |
| Neoplasms, Hormone-Dependent | |
| Receptors, Estrogen | |
| Tumor Cells, Cultured |
Source PubMed
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39409979 | Histone Deacetylase Inhibitors for Peripheral T-Cell Lymphomas. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39409979 | PubMed |
| 37409182 | Parabens Promote Protumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry. | J Endocr Soc | 2023 | https://conductscience.org/library/papers/37409182 | PubMed |
| 37191416 | Phosphatidylethanolamine N-methyltransferase: from Functions to Diseases. | Aging Dis | 2023 | https://conductscience.org/library/papers/37191416 | PubMed |
| 36231059 | The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen. | Cells | 2022 | https://conductscience.org/library/papers/36231059 | PubMed |
| 35976950 | Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity. | PLoS One | 2022 | https://conductscience.org/library/papers/35976950 | PubMed |
| 35163593 | Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163593 | PubMed |
| 33846304 | ATF3 deficiency impairs the proliferative-secretory phase transition and decidualization in RIF patients. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33846304 | PubMed |
| 33688372 | Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival. | Comput Math Methods Med | 2021 | https://conductscience.org/library/papers/33688372 | PubMed |
| 33498407 | Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33498407 | PubMed |
| 33494281 | Using iPSC Models to Understand the Role of Estrogen in Neuron-Glia Interactions in Schizophrenia and Bipolar Disorder. | Cells | 2021 | https://conductscience.org/library/papers/33494281 | PubMed |
| 31847455 | The Microbiome-Estrogen Connection and Breast Cancer Risk. | Cells | 2019 | https://conductscience.org/library/papers/31847455 | PubMed |
| 31652644 | MPT0G612, a Novel HDAC6 Inhibitor, Induces Apoptosis and Suppresses IFN-γ-Induced Programmed Death-Ligand 1 in Human Colorectal Carcinoma Cells. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31652644 | PubMed |
| 31013819 | Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma. | Cells | 2019 | https://conductscience.org/library/papers/31013819 | PubMed |
| 30214302 | Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/30214302 | PubMed |
| 28577574 | Activating transcription factor 3 promotes embryo attachment via up-regulation of leukemia inhibitory factor in vitro. | Reprod Biol Endocrinol | 2017 | https://conductscience.org/library/papers/28577574 | PubMed |
| 28099914 | Advances in epigenetic glioblastoma therapy. | Oncotarget | 2017 | https://conductscience.org/library/papers/28099914 | PubMed |
| 27562495 | QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas. | Mod Pathol | 2016 | https://conductscience.org/library/papers/27562495 | PubMed |
| 26472975 | Potential Prognostic Value of Histone Deacetylase 6 and Acetylated Heat-Shock Protein 90 in Early-Stage Breast Cancer. | J Breast Cancer | 2015 | https://conductscience.org/library/papers/26472975 | PubMed |
| 24399289 | DNA microarray-based gene expression profiling of estrogenic chemicals. | Cell Mol Life Sci | 2014 | https://conductscience.org/library/papers/24399289 | PubMed |
| 24203105 | Detection of estrogen-independent growth-stimulating activity in breast cancer tissues: implication for tumor aggressiveness. | Cancer Microenviron | 2014 | https://conductscience.org/library/papers/24203105 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12370120
GET https://conductscience.org/api/papers/v1/12370120/cited_by?page=2